US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet

Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of...
Reuters Health Information